Qualigen Therapeutics Announces 4.5 Million Private Placement of Convertible Preferred Shares
| 49326EEN9 | 94.55 0.54 0.57% |
About 61% of 49326EEN9's investor base is looking to short. The analysis of the overall prospects from investing in KEY 4789 01 JUN 33 suggests that many traders are, at the present time, alarmed. The current market sentiment, together with 49326EEN9's historical and current headlines, can help investors time the market. In addition, many technical investors use KEY 4789 01 bond news signals to limit their universe of possible portfolio assets.
49326EEN9 |
Carlsbad, CA, Nov. 19, 2024 -- Qualigen Therapeutics, Inc. , Qualigen Therapeutics, Inc., is a life science company focused on developing platform treatments for adult and pediatric cancers, with the potential for orphan drug designations, announced today that it has entered into definitive securities purchase agreements with several institutional and accredited investors for the sale of its preferred shares. Qualigen
Read at finance.yahoo.com
 |
KEY 4789 01 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 49326EEN9 bond to make a market-neutral strategy. Peer analysis of 49326EEN9 could also be used in its relative valuation, which is a method of valuing 49326EEN9 by comparing valuation metrics with similar companies.
Peers
49326EEN9 Related Equities
| 00108WAF7 | 00108WAF7 | 13.49 | ||||
| TRT | Trio Tech | 1.78 | ||||
| BYDDY | BYD Co | 0.60 | ||||
| RCMT | RCM Technologies | 0.41 | ||||
| SMLR | Semler Scientific | 0.19 | ||||
| FRCOF | Fast Retailing | 0.98 | ||||
| RBCAA | Republic Bancorp | 1.19 | ||||
| 90331HPL1 | 90331HPL1 | 2.23 |
Other Information on Investing in 49326EEN9 Bond
49326EEN9 financial ratios help investors to determine whether 49326EEN9 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 49326EEN9 with respect to the benefits of owning 49326EEN9 security.